Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

Amiodarone, one of the most widely prescribed antiarrhythmic drugs to treat both ventricular and supraventricular arrhythmias, has been identified as a candidate drug for use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We present the rationale of using amiodarone in the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Cardiovasc Drugs
Main Authors: Sanchis-Gomar, Fabian, Lavie, Carl J., Morin, Daniel P., Perez-Quilis, Carme, Laukkanen, Jari A., Perez, Marco V.
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2020
Teme:
Current Opinion
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7394926/
https://ncbi.nlm.nih.gov/pubmed/32737841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-020-00429-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki